Clinical Trial Update: Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies [Phase 1]

View source ↗

Summary

This is a Phase 1, multi-institutional trial evaluating expanded multi-antigen oriented lymphocytes for very high-risk hematologic malignancies; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Catherine Bollard | Conditions: Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS | Phase 1 | Status: RECRUITING